FDA Inspection
Catalent Pharma Solutions, LLCCatalent Pharma Solutions, LLC – FDA Inspection, Feb 1, 2023
Record Details
This FDA Inspection record concerns Catalent Pharma Solutions, LLC, with an inspection on February 1, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 29026bc3-0257-48ed-98f2-f7393b135ed7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1199635
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Catalent Pharma Solutions, LLC
12| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | New Jersey District Office | |
| July 13, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 21, 2017 | Not classified | New Jersey District Office | |
| January 17, 2017 | Not classified | New Jersey District Office |
Other documents for Catalent Pharma Solutions, LLC
- FDA Inspection 1285382 - 2025-11-21
- FDA Inspection 1063006 - 2018-07-13
- FDA Inspection 1039238 - 2018-01-19
- FDA Inspection 1024255 - 2017-08-21
- FDA Inspection 996931 - 2017-01-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.